Signaturefd LLC Raises Position in Colgate-Palmolive Company (CL)
Signaturefd LLC raised its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 201.3% during the first quarter, Holdings Channel reports. The institutional investor owned 11,677 shares of the company’s stock after buying an additional 7,802 shares during the period. Signaturefd LLC’s holdings in Colgate-Palmolive were worth $855,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. AlphaMark Advisors LLC increased its stake in shares of Colgate-Palmolive by 452.1% in the first quarter. AlphaMark Advisors LLC now owns 1,673 shares of the company’s stock valued at $122,000 after buying an additional 1,370 shares in the last quarter. North Star Investment Management Corp. increased its stake in Colgate-Palmolive by 3.9% in the first quarter. North Star Investment Management Corp. now owns 1,797 shares of the company’s stock worth $132,000 after buying an additional 67 shares in the last quarter. Blue Chip Partners Inc. increased its stake in Colgate-Palmolive by 0.4% in the first quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock worth $132,000 after buying an additional 8 shares in the last quarter. Advantage Investment Management LLC increased its stake in Colgate-Palmolive by 16.8% in the first quarter. Advantage Investment Management LLC now owns 1,850 shares of the company’s stock worth $135,000 after buying an additional 266 shares in the last quarter. Finally, Heritage Trust Co purchased a new stake in Colgate-Palmolive during the first quarter worth $146,000. 73.85% of the stock is owned by institutional investors and hedge funds.
Shares of Colgate-Palmolive Company (NYSE CL) traded down 0.13% on Friday, hitting $71.46. The company had a trading volume of 896,953 shares. The company has a 50 day moving average price of $72.96 and a 200 day moving average price of $72.71. Colgate-Palmolive Company has a 1-year low of $63.43 and a 1-year high of $77.27. The firm has a market capitalization of $62.94 billion, a price-to-earnings ratio of 26.56 and a beta of 0.80.
Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.72. The business had revenue of $3.83 billion for the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The company’s quarterly revenue was down .5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.70 EPS. On average, equities analysts forecast that Colgate-Palmolive Company will post $2.89 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, August 15th. Shareholders of record on Tuesday, July 18th will be paid a $0.40 dividend. The ex-dividend date is Friday, July 14th. This represents a $1.60 dividend on an annualized basis and a yield of 2.24%. Colgate-Palmolive’s dividend payout ratio is currently 59.48%.
A number of research firms have recently weighed in on CL. UBS AG reissued a “neutral” rating and set a $78.00 target price (down previously from $79.00) on shares of Colgate-Palmolive in a report on Tuesday, May 2nd. Royal Bank Of Canada reissued a “hold” rating and set a $74.00 target price on shares of Colgate-Palmolive in a report on Monday, April 24th. Jefferies Group LLC began coverage on Colgate-Palmolive in a report on Tuesday, April 18th. They set a “hold” rating and a $78.00 target price for the company. BidaskClub downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Saturday, June 24th. Finally, Wells Fargo & Company reissued a “market perform” rating on shares of Colgate-Palmolive in a report on Monday, July 24th. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have issued a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $75.82.
In other Colgate-Palmolive news, Vice Chairman Franck J. Moison sold 35,000 shares of the company’s stock in a transaction dated Monday, August 7th. The stock was sold at an average price of $71.52, for a total value of $2,503,200.00. Following the transaction, the insider now directly owns 201,411 shares in the company, valued at approximately $14,404,914.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Patricia Verduin sold 3,833 shares of the company’s stock in a transaction dated Monday, July 17th. The stock was sold at an average price of $72.41, for a total value of $277,547.53. Following the completion of the transaction, the insider now owns 53,022 shares in the company, valued at $3,839,323.02. The disclosure for this sale can be found here. Insiders sold a total of 203,969 shares of company stock worth $14,711,068 over the last 90 days. Corporate insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.